Cargando…
ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells
Lung cancer is the leading cause of cancer death worldwide, and brain metastasis is a major cause of morbidity and mortality in lung cancer. CDH2 (N-cadherin, a mesenchymal marker of the epithelial-mesenchymal transition) and ADAM9 (a type I transmembrane protein) are related to lung cancer brain me...
Autores principales: | Sher, Yuh-Pyng, Wang, Li-Ju, Chuang, Li-Ling, Tsai, Mong-Hsun, Kuo, Ting-Ting, Huang, Cheng-Chung, Chuang, Eric Y., Lai, Liang-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976390/ https://www.ncbi.nlm.nih.gov/pubmed/24705471 http://dx.doi.org/10.1371/journal.pone.0094065 |
Ejemplares similares
-
ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015) -
Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells
por: Ko, Pin-Hao, et al.
Publicado: (2019) -
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2017) -
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
por: Chou, Cheng-Wei, et al.
Publicado: (2020) -
Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation
por: Lai, Liang-Chuan, et al.
Publicado: (2011)